|
Volumn 14, Issue 1, 2006, Pages 54-60
|
Genetically modified myeloma cell vaccine inducing antitumor immune response in vivo.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
B7 ANTIGEN;
CANCER VACCINE;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
ADENOVIRUS;
ANIMAL;
ARTICLE;
CANCER TRANSPLANTATION;
GENE VECTOR;
GENETICS;
IMMUNOLOGY;
IMMUNOTHERAPY;
MOUSE;
MOUSE MUTANT;
MULTIPLE MYELOMA;
NONOBESE DIABETIC MOUSE;
TUMOR SUPPRESSOR GENE;
ADENOVIRIDAE;
ANIMALS;
ANTIGENS, CD80;
CANCER VACCINES;
GENES, P53;
GENETIC VECTORS;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
IMMUNOTHERAPY;
MICE;
MICE, INBRED NOD;
MICE, SCID;
MULTIPLE MYELOMA;
NEOPLASM TRANSPLANTATION;
|
EID: 36049033667
PISSN: 10092137
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|